Editas Medicine Inc
2.65
$
2.40 %
Editas Medicine Inc se consacre au développement de thérapies génomiques basées sur la technologie CRISPR pour traiter des maladies génétiques.
Price history of Editas Medicine Inc
Price history of Editas Medicine Inc
Performance & Momentum
6 Months
14.40 %
1 Year
52.75 %
3 Years
70.55 %
5 Years
91.74 %
Similar stocks to Editas Medicine Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
